Cargando…

Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective

In cardiovascular surgery, reconstruction and replacement of cardiac and vascular structures are routinely performed. Prosthetic or biological materials traditionally used for this purpose cannot be considered ideal substitutes as they have limited durability and no growth or regeneration potential....

Descripción completa

Detalles Bibliográficos
Autores principales: Durko, Andras P., Yacoub, Magdi H., Kluin, Jolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174659/
https://www.ncbi.nlm.nih.gov/pubmed/32351975
http://dx.doi.org/10.3389/fcvm.2020.00055
_version_ 1783524670675353600
author Durko, Andras P.
Yacoub, Magdi H.
Kluin, Jolanda
author_facet Durko, Andras P.
Yacoub, Magdi H.
Kluin, Jolanda
author_sort Durko, Andras P.
collection PubMed
description In cardiovascular surgery, reconstruction and replacement of cardiac and vascular structures are routinely performed. Prosthetic or biological materials traditionally used for this purpose cannot be considered ideal substitutes as they have limited durability and no growth or regeneration potential. Tissue engineering aims to create materials having normal tissue function including capacity for growth and self-repair. These advanced materials can potentially overcome the shortcomings of conventionally used materials, and, if successfully passing all phases of product development, they might provide a better option for both the pediatric and adult patient population requiring cardiovascular interventions. This short review article overviews the most important cardiovascular pathologies where tissue engineered materials could be used, briefly summarizes the main directions of development of these materials, and discusses the hurdles in their clinical translation. At its beginnings in the 1980s, tissue engineering (TE) was defined as “an interdisciplinary field that applies the principles of engineering and the life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function” (1). Currently, the utility of TE products and materials are being investigated in several fields of human medicine, ranging from orthopedics to cardiovascular surgery (2–5). In cardiovascular surgery, reconstruction and replacement of cardiac and vascular structures are routinely performed. Considering the shortcomings of traditionally used materials, the need for advanced materials that can “restore, maintain or improve tissue function” are evident. Tissue engineered substitutes, having growth and regenerative capacity, could fundamentally change the specialty (6). This article overviews the most important cardiovascular pathologies where TE materials could be used, briefly summarizes the main directions of development of TE materials along with their advantages and shortcomings, and discusses the hurdles in their clinical translation.
format Online
Article
Text
id pubmed-7174659
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71746592020-04-29 Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective Durko, Andras P. Yacoub, Magdi H. Kluin, Jolanda Front Cardiovasc Med Cardiovascular Medicine In cardiovascular surgery, reconstruction and replacement of cardiac and vascular structures are routinely performed. Prosthetic or biological materials traditionally used for this purpose cannot be considered ideal substitutes as they have limited durability and no growth or regeneration potential. Tissue engineering aims to create materials having normal tissue function including capacity for growth and self-repair. These advanced materials can potentially overcome the shortcomings of conventionally used materials, and, if successfully passing all phases of product development, they might provide a better option for both the pediatric and adult patient population requiring cardiovascular interventions. This short review article overviews the most important cardiovascular pathologies where tissue engineered materials could be used, briefly summarizes the main directions of development of these materials, and discusses the hurdles in their clinical translation. At its beginnings in the 1980s, tissue engineering (TE) was defined as “an interdisciplinary field that applies the principles of engineering and the life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function” (1). Currently, the utility of TE products and materials are being investigated in several fields of human medicine, ranging from orthopedics to cardiovascular surgery (2–5). In cardiovascular surgery, reconstruction and replacement of cardiac and vascular structures are routinely performed. Considering the shortcomings of traditionally used materials, the need for advanced materials that can “restore, maintain or improve tissue function” are evident. Tissue engineered substitutes, having growth and regenerative capacity, could fundamentally change the specialty (6). This article overviews the most important cardiovascular pathologies where TE materials could be used, briefly summarizes the main directions of development of TE materials along with their advantages and shortcomings, and discusses the hurdles in their clinical translation. Frontiers Media S.A. 2020-04-15 /pmc/articles/PMC7174659/ /pubmed/32351975 http://dx.doi.org/10.3389/fcvm.2020.00055 Text en Copyright © 2020 Durko, Yacoub and Kluin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Durko, Andras P.
Yacoub, Magdi H.
Kluin, Jolanda
Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective
title Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective
title_full Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective
title_fullStr Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective
title_full_unstemmed Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective
title_short Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective
title_sort tissue engineered materials in cardiovascular surgery: the surgeon's perspective
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174659/
https://www.ncbi.nlm.nih.gov/pubmed/32351975
http://dx.doi.org/10.3389/fcvm.2020.00055
work_keys_str_mv AT durkoandrasp tissueengineeredmaterialsincardiovascularsurgerythesurgeonsperspective
AT yacoubmagdih tissueengineeredmaterialsincardiovascularsurgerythesurgeonsperspective
AT kluinjolanda tissueengineeredmaterialsincardiovascularsurgerythesurgeonsperspective